Serveur d'exploration Chloroquine

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

NEW AND EMERGING THERAPIES FOR COLLAGEN-VASCULAR DISEASES

Identifieur interne : 002453 ( Main/Exploration ); précédent : 002452; suivant : 002454

NEW AND EMERGING THERAPIES FOR COLLAGEN-VASCULAR DISEASES

Auteurs : Jeffrey P. Callen

Source :

RBID : ISTEX:C8FF8CF0DBCABB2E03552D12076A8CE4DD538F45

English descriptors

Abstract

Cutaneous disease is frequent in many of the rheumatic disorders,2 and some of these disorders, such as lupus erythematosus, dermatomyositis, scleroderma, and vasculitis, are defined by their cutaneous manifestations. As investigation increases the understanding of these disorders, available therapies become more logically based and less empiric.

Url:
DOI: 10.1016/S0733-8635(05)70154-6


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI wicri:istexFullTextTei="biblStruct">
<teiHeader>
<fileDesc>
<titleStmt>
<title>NEW AND EMERGING THERAPIES FOR COLLAGEN-VASCULAR DISEASES</title>
<author>
<name sortKey="Callen, Jeffrey P" sort="Callen, Jeffrey P" uniqKey="Callen J" first="Jeffrey P." last="Callen">Jeffrey P. Callen</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:C8FF8CF0DBCABB2E03552D12076A8CE4DD538F45</idno>
<date when="2000" year="2000">2000</date>
<idno type="doi">10.1016/S0733-8635(05)70154-6</idno>
<idno type="url">https://api.istex.fr/ark:/67375/6H6-D21WP6F0-V/fulltext.pdf</idno>
<idno type="wicri:Area/Istex/Corpus">000062</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">000062</idno>
<idno type="wicri:Area/Istex/Curation">000062</idno>
<idno type="wicri:Area/Istex/Checkpoint">001270</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">001270</idno>
<idno type="wicri:doubleKey">0733-8635:2000:Callen J:new:and:emerging</idno>
<idno type="wicri:Area/Main/Merge">002481</idno>
<idno type="wicri:Area/Main/Curation">002453</idno>
<idno type="wicri:Area/Main/Exploration">002453</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title level="a">NEW AND EMERGING THERAPIES FOR COLLAGEN-VASCULAR DISEASES</title>
<author>
<name sortKey="Callen, Jeffrey P" sort="Callen, Jeffrey P" uniqKey="Callen J" first="Jeffrey P." last="Callen">Jeffrey P. Callen</name>
</author>
</analytic>
<monogr></monogr>
<series>
<title level="j">Dermatologic Clinics</title>
<title level="j" type="abbrev">DET</title>
<idno type="ISSN">0733-8635</idno>
<imprint>
<publisher>ELSEVIER</publisher>
<date type="published" when="2000">2000</date>
<biblScope unit="volume">18</biblScope>
<biblScope unit="issue">1</biblScope>
<biblScope unit="page" from="139">139</biblScope>
<biblScope unit="page" to="146">146</biblScope>
</imprint>
<idno type="ISSN">0733-8635</idno>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt>
<idno type="ISSN">0733-8635</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="Teeft" xml:lang="en">
<term>Acad</term>
<term>Acad dermatol</term>
<term>Antimalarial</term>
<term>Antimalarial agents</term>
<term>Arch dermatol</term>
<term>Azathioprine</term>
<term>Callen</term>
<term>Chloroquine</term>
<term>Colchicine</term>
<term>Corticosteroid</term>
<term>Cutaneous</term>
<term>Cutaneous disease</term>
<term>Cutaneous lesions</term>
<term>Cutaneous lupus erythematosus</term>
<term>Cutaneous manifestations</term>
<term>Cutaneous vasculitis</term>
<term>Dapsone</term>
<term>Dermatol</term>
<term>Dermatomyositis</term>
<term>Discoid</term>
<term>Discoid lupus erythematosus</term>
<term>Erythematosus</term>
<term>Hydroxychloroquine</term>
<term>Intravenous immunoglobulin</term>
<term>Lesion</term>
<term>Linear scleroderma</term>
<term>Localized</term>
<term>Localized scleroderma</term>
<term>Lupus</term>
<term>Lupus erythematosus</term>
<term>Methotrexate</term>
<term>Morphea</term>
<term>Phenytoin</term>
<term>Refractory</term>
<term>Rheumatoid arthritis</term>
<term>Rheumatol</term>
<term>Scleroderma</term>
<term>Systemic</term>
<term>Systemic corticosteroids</term>
<term>Systemic lupus erythematosus</term>
<term>Thalidomide</term>
<term>Therapy</term>
<term>Toxic effects</term>
<term>Vasculitis</term>
</keywords>
</textClass>
<langUsage>
<language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
<front>
<div type="abstract">Cutaneous disease is frequent in many of the rheumatic disorders,2 and some of these disorders, such as lupus erythematosus, dermatomyositis, scleroderma, and vasculitis, are defined by their cutaneous manifestations. As investigation increases the understanding of these disorders, available therapies become more logically based and less empiric.</div>
</front>
</TEI>
<affiliations>
<list></list>
<tree>
<noCountry>
<name sortKey="Callen, Jeffrey P" sort="Callen, Jeffrey P" uniqKey="Callen J" first="Jeffrey P." last="Callen">Jeffrey P. Callen</name>
</noCountry>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/ChloroquineV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002453 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 002453 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    ChloroquineV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     ISTEX:C8FF8CF0DBCABB2E03552D12076A8CE4DD538F45
   |texte=   NEW AND EMERGING THERAPIES FOR COLLAGEN-VASCULAR DISEASES
}}

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Wed Mar 25 22:43:59 2020. Site generation: Sun Jan 31 12:44:45 2021